Next Article in Journal
Health-Related Quality of Life in Patients with Primary Adrenal Insufficiency
Previous Article in Journal
The Influence of Socioeconomic Factors on Access to Biologics in Psoriasis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3

by
Madina R. Zhalbinova
1,2,
Saule E. Rakhimova
1,
Ulan A. Kozhamkulov
1,
Gulbanu A. Akilzhanova
3,
Assel A. Chinybayeva
4,
Kenes R. Akilzhanov
3,
Nurlan K. Shaimardanov
5,
Anargul G. Kuanysheva
5,
Joseph H. Lee
6,
Ulykbek Y. Kairov
1,
Makhabbat S. Bekbossynova
7 and
Ainur R. Akilzhanova
1,2,8,*
1
National Laboratory Astana, Nazarbayev University, Astana 010000, Kazakhstan
2
Department of General Biology and Genomics, L. N. Gumilyov Eurasian National University, Astana 010000, Kazakhstan
3
Department of Medicine, Semey Medical University, Pavlodar Branch, Pavlodar 140000, Kazakhstan
4
Republic Diagnostic Center, CF “University Medical Center”, Astana 010000, Kazakhstan
5
Department of Medicine, Semey Medical University, Semey 071400, Kazakhstan
6
Sergievsky Center, Taub Institute, Columbia University Medical Center, New York, NY 10032, USA
7
National Research Cardiac Surgery Center, Astana 010000, Kazakhstan
8
Atomic Bomb Disease Institute, Nagasaki University, Nagasaki 852-8523, Japan
*
Author to whom correspondence should be addressed.
J. Clin. Med. 2023, 12(23), 7235; https://doi.org/10.3390/jcm12237235
Submission received: 15 September 2023 / Revised: 10 November 2023 / Accepted: 17 November 2023 / Published: 22 November 2023
(This article belongs to the Topic Mechanical Circulatory Support in Heart Failure)

Abstract

Left ventricular assist device (LVAD) implantation is one of the mechanical circulatory support (MCS) treatments for advanced heart failure (HF) patients. MCS has emerged as a lifesaving therapy that improves patients’ quality of life. However, MCS remains limited by a paradoxical coagulopathy accompanied by thrombosis and bleeding. The mechanisms of MCS thrombosis are increasingly being defined, but MCS-related bleeding, which is related to shear-mediated alteration of platelet function, remains poorly understood. Complications might develop due to the high non-physiological shear stress in the device and as a consequence of individual variability in response to the antithrombotic therapy. Thromboelastography (TEG) and genotyping of gene polymorphisms that are involved in the coagulation cascade and in the metabolism of the antithrombotic therapy might be valuable sources of information for the reduction of complication development. The aim of the study was to identify genetic factors related to the development of device complications according to the implanted LVAD type. We compared the clinical and genetic data of HF patients (n = 98) with/without complications with three types of implanted devices: HeartWare HVAD (HW), HeartMate II (HMII), and HeartMate 3 (HM3). rs9923231 in VKORC1 (95%CI −6.28–0.22, p = 0.04) and rs5918 in ITGB3 genes (95%CI 0.003–4.36, p = 0.05) showed significant association with the TEG coagulation index parameter, which identified hyper- and hypo-coagulation states. The wild genotype of rs5918 in the ITGB3 gene prevailed in patients implanted with HM3 devices, which developed fewer complications than with HMII (p = 0.04). Individual genetic information could be useful in the management of patients with HF and the implantation of MCS to reduce the development of complications.
Keywords: genotype; polymorphism; heart failure; left ventricular assist device (LVAD); mechanical circulatory support (MCS) genotype; polymorphism; heart failure; left ventricular assist device (LVAD); mechanical circulatory support (MCS)

Share and Cite

MDPI and ACS Style

Zhalbinova, M.R.; Rakhimova, S.E.; Kozhamkulov, U.A.; Akilzhanova, G.A.; Chinybayeva, A.A.; Akilzhanov, K.R.; Shaimardanov, N.K.; Kuanysheva, A.G.; Lee, J.H.; Kairov, U.Y.; et al. Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3. J. Clin. Med. 2023, 12, 7235. https://doi.org/10.3390/jcm12237235

AMA Style

Zhalbinova MR, Rakhimova SE, Kozhamkulov UA, Akilzhanova GA, Chinybayeva AA, Akilzhanov KR, Shaimardanov NK, Kuanysheva AG, Lee JH, Kairov UY, et al. Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3. Journal of Clinical Medicine. 2023; 12(23):7235. https://doi.org/10.3390/jcm12237235

Chicago/Turabian Style

Zhalbinova, Madina R., Saule E. Rakhimova, Ulan A. Kozhamkulov, Gulbanu A. Akilzhanova, Assel A. Chinybayeva, Kenes R. Akilzhanov, Nurlan K. Shaimardanov, Anargul G. Kuanysheva, Joseph H. Lee, Ulykbek Y. Kairov, and et al. 2023. "Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3" Journal of Clinical Medicine 12, no. 23: 7235. https://doi.org/10.3390/jcm12237235

APA Style

Zhalbinova, M. R., Rakhimova, S. E., Kozhamkulov, U. A., Akilzhanova, G. A., Chinybayeva, A. A., Akilzhanov, K. R., Shaimardanov, N. K., Kuanysheva, A. G., Lee, J. H., Kairov, U. Y., Bekbossynova, M. S., & Akilzhanova, A. R. (2023). Role of Genetic Polymorphisms in the Development of Complications in Patients with Implanted Left Ventricular Assist Devices: HeartWare, HeartMate II, and HeartMate 3. Journal of Clinical Medicine, 12(23), 7235. https://doi.org/10.3390/jcm12237235

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop